Medable’s New Intelligent Automation Capabilities Cut Clinical Trial Technology Deployment Timelines By 50%
AI-powered* platform takes eCOA off the critical path to study startup for life sciences industry PALO ALTO, Calif.–(BUSINESS WIRE)–#biotech—Medable... Read more.
Cybin Announces Positive Topline Data from Phase 1 Studies of Proprietary Deuterated DMT Molecules CYB004 and SPL028
– Intravenous (“IV”) CYB004 demonstrated robust and rapid-onset psychedelic effects at lower doses compared to native DMT, suggesting potential as a short-acting,... Read more.
Merck to Acquire Harpoon Therapeutics, Further Diversifying Oncology Pipeline
Acquisition includes HPN328, an investigational delta-like ligand 3 (DLL3) targeting T-cell engager being evaluated in certain patients with small cell lung cancer... Read more.
Johnson & Johnson to Acquire Ambrx, Advancing Next Generation Antibody Drug Conjugates to Transform the Treatment of Cancer
Portfolio of Clinical and Preclinical Programs, Including Lead Product Candidate ARX517, a Prostate-Specific Membrane Antigen (PSMA)-Targeting Antibody Drug Conjugate... Read more.
Aramark Launches New Telehealth Program to Digitally Connect Hospital Inpatients with Clinical Nutrition Services
First of its kind program with Teladoc Health® provides hospitals with access to both technology and talent. PHILADELPHIA–(BUSINESS WIRE)–$ARMK—Aramark... Read more.
PGT Innovations Board of Directors Determines that Miter’s Unsolicited Proposal Would Reasonably Be Expected to Lead to a Superior Proposal
VENICE, Fla.–(BUSINESS WIRE)–PGT Innovations, Inc. (NYSE: PGTI) (“PGTI” or the “Company”), a national leader in premium windows and doors, today... Read more.
Camping World Set to Acquire Three Locations in Texas and Oklahoma
LINCOLNSHIRE, Ill.–(BUSINESS WIRE)–Camping World Holdings, Inc. (NYSE: CWH) (“Camping World”), the World’s Largest Recreational Vehicle Dealer,... Read more.
Organon affirms 2023 revenue and Adjusted EBITDA guidance and provides 2024 outlook
Regular dividend to remain primary capital allocation priority For full year 2023, the company expects revenue and Adjusted EBITDA margin to be within the ranges... Read more.
Capstan Therapeutics Appoints Ramin Farzaneh-Far, M.D., as Chief Medical Officer and Announces Key Business Leadership Promotion
SAN DIEGO–(BUSINESS WIRE)–Capstan Therapeutics, Inc. (“Capstan”), a biotechnology company dedicated to advancing in vivo reprogramming of cells through... Read more.
Bread FinancialTM Announces Private Offering of Additional 9.750% Senior Notes Due 2029
COLUMBUS, Ohio–(BUSINESS WIRE)–Bread Financial Holdings, Inc. (NYSE: BFH) (“Bread Financial” or the “Company”) announced today that it intends... Read more.